APOB and chronic kidney disease: The association of the apoB/A-I ratio with coronary heart disease incidence in individuals with CKD, which was defined as an eGFR of 15 to <60 mL/min/1.73 m2, was similar to that observed for other lipid measurements in the population-based cohort study.